Ledger.Open graph →
SEC Form D · filed March 1, 2017

Tetragenetics Inc

Offering
$2.0M
Sold
$1.1M
Exemption
Rule 506(b)
Industry
Biotechnology
Location
Arlington, MA
Type
—

Rule 506(b): private placement to accredited investors, no public advertising.

People & firms on this filing (19)

Christopher Taron · Essex, MADirectorRobert D. Gailus · New York, NYDirectorPeter D. Kiener · Potomac, MDDirectorMartin D. Gorovsky · Somerset, NJDirectorKevin D. O'Brien · Acton, MAExecTheodore Clark · Ithaca, NYExec · DirectorHal Luftig · New York, NYExecRobert E. Akridge · SEATTLE, WADirectorAvi Lewittes · CHICAGO, ILExec · DirectorTim A. Prince · MIDDLETON, WIDirectorDonna A. Katen-Bahensky · MIDDLETON, WIDirectorR D. Kahn · Boston, MAExec · DirectorJacob P. Moskol · MIDDLETON, WIDirectorDavid Zolty · TEL AVIV, L3DirectorBen Friedman · Tel Aviv, L3DirectorMarshall Cannon · BETHESDA, MDExecMary Schulman · BETHESDA, MDDirectorJoe Oblas · Plano, TXExec · DirectorR D. Kahn · Boston, MAExec · Director

Public SEC Form D (Reg D) filing. · View issuer on SEC EDGAR ↗